CClinicalTrials.gg
CompletedNCT06934837Updated Apr 18, 2025

Evaluation of Swallowing Muscles Using Ultrasonography and Shear Wave Elastography in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma Diagnosis

An observational study in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma Diagnosis, Ultrasonography and Shear Wave Elastography and Evaluation of Swallowing Muscles, sponsored by Konya Beyhekim Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-18.

Sponsored by Konya Beyhekim Training and Research Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
32
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the mylohyoid, geniohyoid and digastric muscles in patients with radiotherapy-induced dysphagia due to nasopharynx cancer using ultrasonography and shear wave elastography (SWE).

Read the detailed description

Post-radiotherapy swallowing dysfunction evaluation was carried out using fibreoptic endoscopic evaluation (FEES), ultrasonography of the swallowing muscles, shear wave elastography and swallowing assessment scale between the dates of 01/01/2023 and 01/06/2023.

All patients were interviewed to obtain detailed medical histories. Following this, standardized swallowing assessments were administered, including the Eating Assessment Tool (EAT-10) and the M.D. Anderson Dysphagia Inventory (MDADI). Head and neck examination, endoscopic examination and fibreoptic endoscopic swallowing assessment were performed at the Otorhinolaryngology, Head and Neck Surgery clinic. Penetration Aspiration Score (PAS) was determined by the experienced faculty member. Afterwards, an experienced radiologist performed neck ultrasonography and shear wave elastography (SWE) using an Aplio 500 Platinium Ultrasonography system (Toshiba Medical Systems, Japan) equipped with high-frequency linear transducer (frequency range = 5-14 MHz). With SWE, the stiffness values of the mylohyoid, geniohyoid and digastric muscles were measured in m/s and kPa, and their thickness was measured in mm. The tissue elasticity was outlined using a colour-coded system ranging from dark blue indicating least stiffness to red representing greatest stiffness, with a default measurement range of 0-120 kPa. The elastic value E (kPa) is calculated using the equation E = 3 ρ (m/s) 2. In the equation, m/s represents the shear wave propagation speed, and ρ represents the tissue density (approximately 1 in humans). All patients receiving radiotherapy were treated in our hospital's radiation oncology clinic for Stage I nasopharyngeal cancer received 70 Gy (2,12 Gy/Gun) gross tumour value (CTV70), with 5-10 mm margin for microscopic spread, delivered according to the International Commission on Radiation Units and Measurements (ICRU) Reports 50 and 62 guidelines. After obtaining the data, comparisons between the groups and correlations between the quantitative data were assessed using appropriate statistical methods.

02

Conditions studied

  • Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma Diagnosis
  • Ultrasonography and Shear Wave Elastography
  • Evaluation of Swallowing Muscles

Keywords

  • Dysphagia
  • Nasopharynx cancer
  • SWE
  • Swallowing disorders
03

In context

Carcinoma

6,741 studies on the registry are indexed under Carcinoma; 1,161 are open to participants now.

This study's enrollment of 32 is below the median of 149 across 1,175 observational studies indexed under Carcinoma.

Browse Carcinoma studies →

Lead sponsor

Konya Beyhekim Training and Research Hospital is the lead sponsor of 31 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

18 or older than 65 years receiving radiotherapy, presented with dysphagia.

Inclusion criteria

Patient Group:

  • Volunteered for the study.
  • Aged 18-65 years.
  • Diagnosed with Stage I nasopharynx cancer.
  • Completed radiotherapy treatment at least 12 months prior to the study.
  • No additional cancer diagnoses.
  • No history of chemo-radiotherapy.
  • No prior head-neck trauma or surgery.
  • No rheumatologic or neuromuscular disorders.
  • No pre-existing swallowing disorders.
  • Control Group (Healthy Volunteers):

Control group:

  • Aged 18-65 years.
  • No history of head and neck cancer.
  • No prior neck surgery or trauma.
  • No radiotherapy to the head and neck region.
  • No rheumatologic or neuromuscular disorders.
  • No central haemorrhagic or ischemic disease.
  • No pre-existing swallowing disorders.

Exclusion criteria

Exclusion Criterias:

  • Younger than 18 years or older than 65 years.
  • Any history of neck interventions (e.g., for cancer metastasis, cervical spine surgery, trauma).
  • Presence of systemic conditions potentially causing dysphagia (e.g., neurological, rheumatological, metabolic, or muscular disorders).
  • Previous radiotherapy for reasons other than Stage I nasopharynx cancer (in the patient group).
  • Any other cancer diagnosis besides Stage I nasopharynx cancer (in the patient group).
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
32 participants (actual)
Patient registry
No

Groups and cohorts

  • Nasopharynx canser (disease group)

    16 Stage I nasopharynx cancer patients receiving radiotherapy

  • Control (healthy) group

    16 healthy volunteers from the otorhinolaryngology outpatient clinic

06

What researchers measure

Primary outcomes

  1. Swallowing muscle thickness

    Right and left digastric - mylohyoid muscle thickness, as well as geniohyoid thickness using ultrasonography and Shear Wave Elastography. The thickness values of the mylohyoid, geniohyoid and digastric muscles were measured in mm by experienced radiologist.

    Time frame: 12 months after radiotherapy.

  2. Swallowing muscle pressure

    Right and left digastric - mylohyoid muscle pressure, as well as geniohyoid pressure using ultrasonography and Shear Wave Elastography. The outcome pressure is measured in kPA by an experienced radiologist .

    Time frame: 12 months after radiotherapy.

  3. Swallowing muscle velocity

    Right and left digastric - mylohyoid muscle velocity, as well as geniohyoid velocity using ultrasonography and Shear Wave Elastography. The velocity values of the mylohyoid, geniohyoid and digastric muscles were measured in m/s by an experienced radiologist.

    Time frame: 12 months after radiotherapy.

07

Study locations

1 site
  • Selçuk University Faculty of Medicine Hospital
    Konya, 42020, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided — All data generated or analysed during this study are included in this research. Further inquiries or requests regarding the patient data can be directed to the corresponding author when necessary.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06934837
Lead sponsor
Konya Beyhekim Training and Research Hospital
Collaborators
Selcuk University
Responsible party
Fatih İkiz (Principal Investigator, Konya Beyhekim Training and Research Hospital) — Principal investigator
First posted
Apr 18, 2025
Start date
Jan 1, 2023
Primary completion
Jun 1, 2023
Completion
Jun 1, 2023
Last update
Apr 18, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion